BioSTAR Evaluation STudy (BEST): A Prospective, Multicenter, Phase I Clinical Trial to Evaluate the Feasibility, Efficacy, and Safety of the BioSTAR Bioabsorbable Septal Repair Implant for the Closure of Atrial-Level Shunts
Circulation - United States
doi 10.1161/circulationaha.106.664672
Full Text
Open PDFAbstract
Available in full text
Date
October 31, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)